Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID‐19: An Open‐Label Randomized Controlled Pilot Study

This open‐label randomized controlled pilot study aimed to test the study feasibility of bromhexine hydrochloride (BRH) tablets for the treatment of mild or moderate coronavirus disease 2019 (COVID‐19) and to explore its clinical efficacy and safety. Patients with mild or moderate COVID‐19 were rand...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Sci
Main Authors: Li, Ting, Sun, Laifang, Zhang, Wenwu, Zheng, Chanfan, Jiang, Chenchen, Chen, Mingjing, Chen, Di, Dai, Zhijuan, Bao, Shihui, Shen, Xian
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7719397/
https://ncbi.nlm.nih.gov/pubmed/32881359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12881
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados